Skip to main
GEHC

GEHC Stock Forecast & Price Target

GEHC Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 21%
Buy 29%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

GE HealthCare Techs is a leading medical technology firm with a diverse product portfolio and strong market share in imaging and ultrasound equipment globally. Despite inflationary pressures and supply chain disruptions affecting their margins in the short term, the company is well-positioned for long-term sustainable growth in the $110B healthcare market. Their track record of mitigating cost increases and ability to introduce new, higher-ASP products should drive future margins and shareholder value.

Bears say

GE HealthCare Techs is facing headwinds, including declining revenue in the patient care solutions segment due to concentrated monitoring installations and a decline in China's sales. While the company has strong market share in imaging and ultrasound equipment, the recent tariff and inflationary impacts on the P&L have hindered margin expansion. Furthermore, there is a risk of macroeconomic challenges and competition in the global market, as well as potential regulatory challenges in international markets, which could negatively affect future revenue growth.

GEHC has been analyzed by 14 analysts, with a consensus rating of Buy. 21% of analysts recommend a Strong Buy, 29% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GE HealthCare Technologies Inc (GEHC) Forecast

Analysts have given GEHC a Buy based on their latest research and market trends.

According to 14 analysts, GEHC has a Buy consensus rating as of Jun 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $81.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $81.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GE HealthCare Technologies Inc (GEHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.